TNBC

Results: 13



#Item
1Final_ENMD2076_ph2_TNBC_Diamond120117

Final_ENMD2076_ph2_TNBC_Diamond120117

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2017-12-07 08:42:21
2SOUTHERN ARIZONA CLINICAL TRIALS Breast Cancer Veliparib ABT-888 Neoadj TNBC Brentuximab Vedotin in Older Pts with HL

SOUTHERN ARIZONA CLINICAL TRIALS Breast Cancer Veliparib ABT-888 Neoadj TNBC Brentuximab Vedotin in Older Pts with HL

Add to Reading List

Source URL: arizonaoncology.com

Language: English - Date: 2015-11-02 17:01:58
    3Triple Negative Breast Cancer, 2014: Expert Perspectives A Guide for Patients This guide is based on an expert panel discussion titled

    Triple Negative Breast Cancer, 2014: Expert Perspectives A Guide for Patients This guide is based on an expert panel discussion titled "Triple

    Add to Reading List

    Source URL: www.tnbcfoundation.org

    Language: English - Date: 2014-03-31 17:21:25
    4Award ID: DP150069 Project Title: Oral Stat3 Inhibitor as Targeted Treatment for Triple-Negative Breast Cancer Award Mechanism:

    Award ID: DP150069 Project Title: Oral Stat3 Inhibitor as Targeted Treatment for Triple-Negative Breast Cancer Award Mechanism:

    Add to Reading List

    Source URL: www.cprit.state.tx.us

    Language: English - Date: 2014-11-20 01:49:42
    5Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award

    Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award

    Add to Reading List

    Source URL: www.cprit.state.tx.us

    Language: English - Date: 2014-11-20 01:49:44
    6Award ID: DP150064 Project Title: Novel Separase Inhibitors to Treat Refractory Breast Cancer Award Mechanism: Bridging the Gap: Early Translational Research Awards

    Award ID: DP150064 Project Title: Novel Separase Inhibitors to Treat Refractory Breast Cancer Award Mechanism: Bridging the Gap: Early Translational Research Awards

    Add to Reading List

    Source URL: www.cprit.state.tx.us

    Language: English - Date: 2014-11-20 01:49:42
    74th Asia-Pacific Breast Cancer Summit Reaching New Heights in Breast Cancer Care BRISBANE 2015

    4th Asia-Pacific Breast Cancer Summit Reaching New Heights in Breast Cancer Care BRISBANE 2015

    Add to Reading List

    Source URL: www.breastsummit.org

    Language: English - Date: 2015-02-04 05:58:22
    813058_2015_544_Article 1..14

    13058_2015_544_Article 1..14

    Add to Reading List

    Source URL: breast-cancer-research.com

    Language: English
    9SPEECH BY THE PRESIDENT OF THE UNITED REPUBLIC OF TANZANIA, AND CHAIRPERSON OF THE TANZANIA NATIONAL BUSINESS COUNCIL (TNBC), HIS EXCELLENCY BENJAMIN WILLIAM MKAPA, AT A TNBC DINNER, GOLDEN TULIP HOTEL, DAR ES SALAAM, 15

    SPEECH BY THE PRESIDENT OF THE UNITED REPUBLIC OF TANZANIA, AND CHAIRPERSON OF THE TANZANIA NATIONAL BUSINESS COUNCIL (TNBC), HIS EXCELLENCY BENJAMIN WILLIAM MKAPA, AT A TNBC DINNER, GOLDEN TULIP HOTEL, DAR ES SALAAM, 15

    Add to Reading List

    Source URL: www.egov.go.tz

    Language: English - Date: 2014-11-12 06:43:30
    10Sanofi-aventis To Acquire BiPar Sciences First-in-class oncology medicine will provide new treatment option while adding to the company’s late stage development portfolio BRISBANE, California and PARIS, France – Apri

    Sanofi-aventis To Acquire BiPar Sciences First-in-class oncology medicine will provide new treatment option while adding to the company’s late stage development portfolio BRISBANE, California and PARIS, France – Apri

    Add to Reading List

    Source URL: capital.vulcan.com

    Language: English - Date: 2009-05-13 16:49:54